Literature DB >> 17568117

Expression profiling using affymetrix genechip probe arrays.

Martina Schinke-Braun1, Jennifer A Couget.   

Abstract

Large-scale microarray expression profiling studies have helped us to understand basic biological processes and to classify and predict the prognosis of cancers; they have also accelerated the identification of new drug targets. Affymetrix GeneChip probe arrays are high-density oligonucleotide microarrays that are available for many prokaryotic and eukaryotic species. Affymetrix human and mouse whole-genome microarrays analyze the expression level of up to 47,000 transcripts and variants. Each transcript is measured by 11 probe pairs, which consist of a perfect match 25mer oligonucleotide (PM) and a 25mer mismatch oligonucleotide (MM) that contains a single base pair mismatch in the central position. The PM/MM design is used for identification and subtraction of nonspecific hybridization and background signals. Advantages of Affymetrix GeneChip arrays include highly standardized array fabrication, as well as standardized target preparation, hybridization, and processing protocols, resulting in low technical variability and good reproducibility between experiments. This chapter describes the standard assay procedures for isolating total RNA from heart tissue, generating a biotin-labeled target for expression analysis, processing of Affymetrix GeneChip probe arrays using the Affymetrix instrument system, and quality control measures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568117     DOI: 10.1007/978-1-59745-030-0_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Standards affecting the consistency of gene expression arrays in clinical applications.

Authors:  Steven A Enkemann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

Review 2.  Carbon Substrates: A Stable Foundation for Biomolecular Arrays.

Authors:  Matthew R Lockett; Lloyd M Smith
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2015-06-03       Impact factor: 10.745

3.  Transcriptome Analysis of Mycobacteria-Specific CD4+ T Cells Identified by Activation-Induced Expression of CD154.

Authors:  Shajo Kunnath-Velayudhan; Michael F Goldberg; Neeraj K Saini; Christopher T Johndrow; Tony W Ng; Alison J Johnson; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2017-08-18       Impact factor: 5.422

4.  Quality assessment of microarray data in a multicenter study.

Authors:  Kellie J Archer; Valeria R Mas; Thomas R O'Brien; Ruth Pfeiffer; Nicole L Lum; Robert A Fisher
Journal:  Diagn Mol Pathol       Date:  2009-03

5.  Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis.

Authors:  William R Swindell; Xianying Xing; Philip E Stuart; Cynthia S Chen; Abhishek Aphale; Rajan P Nair; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  Cystatin F is a biomarker of prion pathogenesis in mice.

Authors:  Mario Nuvolone; Nicolas Schmid; Gino Miele; Silvia Sorce; Rita Moos; Christian Schori; Roger R Beerli; Monika Bauer; Philippe Saudan; Klaus Dietmeier; Ingolf Lachmann; Michael Linnebank; Roland Martin; Ulf Kallweit; Veronika Kana; Elisabeth J Rushing; Herbert Budka; Adriano Aguzzi
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

7.  PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification.

Authors:  Athanasia Spandidos; Xiaowei Wang; Huajun Wang; Brian Seed
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

8.  A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance.

Authors:  Athanasia Spandidos; Xiaowei Wang; Huajun Wang; Stefan Dragnev; Tara Thurber; Brian Seed
Journal:  BMC Genomics       Date:  2008-12-24       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.